FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2600452401> ?p ?o ?g. }

• W2600452401 endingPage "38043" @default.
• W2600452401 startingPage "38022" @default.
• W2600452401 abstract "// Reza Bayat Mokhtari 1,2,4 , Tina S. Homayouni 1 , Narges Baluch 3 , Evgeniya Morgatskaya 1 , Sushil Kumar 1 , Bikul Das 4 and Herman Yeger 1,2 1 Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada 2 Department of Paediatric Laboratory Medicine, The Hospital for Sick Children and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada 3 Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada 4 Department of Immunology and Infectious Diseases, The Forsyth Institute, Cambridge, Massachusetts, USA Correspondence to: Herman Yeger, email: // Reza Bayat Mokhtari, email: // Keywords : Nrf2-Keap1, HIF-1alpha, carbonic anhydrase 9 (CAIX), histone deacetylase inhibitor (HDACi), carbonic anhydrase inhibitor (CAI) Received : October 19, 2016 Accepted : February 27, 2017 Published : March 30, 2017 Abstract Combination therapy, a treatment modality that combines two or more therapeutic agents, is a cornerstone of cancer therapy. The amalgamation of anti-cancer drugs enhances efficacy compared to the mono-therapy approach because it targets key pathways in a characteristically synergistic or an additive manner. This approach potentially reduces drug resistance, while simultaneously providing therapeutic anti-cancer benefits, such as reducing tumour growth and metastatic potential, arresting mitotically active cells, reducing cancer stem cell populations, and inducing apoptosis. The 5-year survival rates for most metastatic cancers are still quite low, and the process of developing a new anti-cancer drug is costly and extremely time-consuming. Therefore, new strategies that target the survival pathways that provide efficient and effective results at an affordable cost are being considered. One such approach incorporates repurposing therapeutic agents initially used for the treatment of different diseases other than cancer. This approach is effective primarily when the FDA-approved agent targets similar pathways found in cancer. Because one of the drugs used in combination therapy is already FDA-approved, overall costs of combination therapy research are reduced. This increases cost efficiency of therapy, thereby benefiting the “medically underserved”. In addition, an approach that combines repurposed pharmaceutical agents with other therapeutics has shown promising results in mitigating tumour burden. In this systematic review, we discuss important pathways commonly targeted in cancer therapy. Furthermore, we also review important repurposed or primary anti-cancer agents that have gained popularity in clinical trials and research since 2012." @default.
• W2600452401 created "2017-04-07" @default.
• W2600452401 creator A5005931876 @default.
• W2600452401 creator A5021937638 @default.
• W2600452401 creator A5026663250 @default.
• W2600452401 creator A5026699953 @default.
• W2600452401 creator A5040319282 @default.
• W2600452401 creator A5049914982 @default.
• W2600452401 creator A5086700020 @default.
• W2600452401 date "2017-03-30" @default.
• W2600452401 modified "2023-10-14" @default.
• W2600452401 title "Combination therapy in combating cancer" @default.
• W2600452401 cites W1245741737 @default.
• W2600452401 cites W131994123 @default.
• W2600452401 cites W1557568886 @default.
• W2600452401 cites W1577460040 @default.
• W2600452401 cites W1627803359 @default.
• W2600452401 cites W1671049130 @default.
• W2600452401 cites W1735537822 @default.
• W2600452401 cites W1896801189 @default.
• W2600452401 cites W1930102516 @default.
• W2600452401 cites W1964403908 @default.
• W2600452401 cites W1965035936 @default.
• W2600452401 cites W1965281877 @default.
• W2600452401 cites W1966526747 @default.
• W2600452401 cites W1967953173 @default.
• W2600452401 cites W1969909043 @default.
• W2600452401 cites W1975433241 @default.
• W2600452401 cites W1976768416 @default.
• W2600452401 cites W1977191081 @default.
• W2600452401 cites W1977334935 @default.
• W2600452401 cites W1978103469 @default.
• W2600452401 cites W1978281808 @default.
• W2600452401 cites W1980739328 @default.
• W2600452401 cites W1987857240 @default.
• W2600452401 cites W1989109875 @default.
• W2600452401 cites W1990180383 @default.
• W2600452401 cites W1990331048 @default.
• W2600452401 cites W1990923495 @default.
• W2600452401 cites W1991085679 @default.
• W2600452401 cites W1991248698 @default.
• W2600452401 cites W1993510744 @default.
• W2600452401 cites W1993653750 @default.
• W2600452401 cites W1994557380 @default.
• W2600452401 cites W1996036500 @default.
• W2600452401 cites W1998188518 @default.
• W2600452401 cites W1998783968 @default.
• W2600452401 cites W2000292756 @default.
• W2600452401 cites W2001504740 @default.
• W2600452401 cites W2002013266 @default.
• W2600452401 cites W2006434892 @default.
• W2600452401 cites W2008757142 @default.
• W2600452401 cites W2009060922 @default.
• W2600452401 cites W2009183786 @default.
• W2600452401 cites W2009671306 @default.
• W2600452401 cites W2010646521 @default.
• W2600452401 cites W2012762703 @default.
• W2600452401 cites W2013241912 @default.
• W2600452401 cites W2015645056 @default.
• W2600452401 cites W2025050104 @default.
• W2600452401 cites W2025652939 @default.
• W2600452401 cites W2027694152 @default.
• W2600452401 cites W2027910813 @default.
• W2600452401 cites W2028705988 @default.
• W2600452401 cites W2028846884 @default.
• W2600452401 cites W2029067093 @default.
• W2600452401 cites W2030858021 @default.
• W2600452401 cites W2031735452 @default.
• W2600452401 cites W2032585021 @default.
• W2600452401 cites W2032936106 @default.
• W2600452401 cites W2034244318 @default.
• W2600452401 cites W2035447242 @default.
• W2600452401 cites W2035880310 @default.
• W2600452401 cites W2035921027 @default.
• W2600452401 cites W2036654287 @default.
• W2600452401 cites W2039109621 @default.
• W2600452401 cites W2046429130 @default.
• W2600452401 cites W2046736738 @default.
• W2600452401 cites W2047178318 @default.
• W2600452401 cites W2047521631 @default.
• W2600452401 cites W2048306047 @default.
• W2600452401 cites W2050720471 @default.
• W2600452401 cites W2051017731 @default.
• W2600452401 cites W2051349300 @default.
• W2600452401 cites W2052335855 @default.
• W2600452401 cites W2053103409 @default.
• W2600452401 cites W2053178768 @default.
• W2600452401 cites W2054085969 @default.
• W2600452401 cites W2054796618 @default.
• W2600452401 cites W2056030791 @default.
• W2600452401 cites W2056181814 @default.
• W2600452401 cites W2059294866 @default.
• W2600452401 cites W2059378857 @default.
• W2600452401 cites W2062941476 @default.
• W2600452401 cites W2063819389 @default.
• W2600452401 cites W2065817738 @default.
• W2600452401 cites W2066378783 @default.
• W2600452401 cites W2067708335 @default.

• next